A Study of Capecitabine (Xeloda) in Participants With Locally Advanced or Metastatic Pancreatic Cancer
Clinical trial NCT02565641 · COMPLETED
Trial details
- NCT number
- NCT02565641
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-03-01
- Primary completion
- 2006-09-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.